ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,69
0,14%
Dow Jones
43 325,80
0,07%
DAX
19 848,77
-0,34%
Brent Oil
72,825
-0,63%
Bitcoin
95 449,41
-3,88%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Rafarma Pharmaceuticals Inc (PK) (RAFA) Cours

Rafarma Pharmaceuticals Inc (PK)

Rafarma Pharmaceuticals Inc (PK) (RAFA)

USOTC
0,07445
0,00495
(7,12%)
Fermé 26 Décembre 10:00PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,07445
Prix Achat
0,0695
Prix Vente
0,089
Volume échangé
10 000
0,07445 Fourchette du Jour 0,07445
0,033 Plage de 52 semaines 0,30
Cap du marché
6,534M
Clôture Veille
0,0695
Ouverture
0,07445
Dernière Transaction
10000
@
0.07445
Dernière heure de transaction
Volume financier
US$ 745
VWAP
0,07445
Volume moyen (3 m)
34 807
Actions en circulation
87 766 999
Rendement du Dividende
-
Ratio Cours sur Bénéfices
22,58
Bénéfice par action (BPA)
-
Chiffre d'affairess
10,14M
Bénéfice net
273k

À propos de Rafarma Pharmaceuticals Inc (PK)

Rafarma is a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, vaccines and specialty Pharma products in Europe & Asia. Rafarma is a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, vaccines and specialty Pharma products in Europe & Asia.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
rafarma.si
Siège social
Sheridan, Wyoming, USA
Fondé
-
Rafarma Pharmaceuticals Inc (PK) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker RAFA. Le dernier cours de clôture d'Rafarma Pharmaceuticals (PK) était de US$0,07. Au cours de la dernière année, les actions de Rafarma Pharmaceuticals (PK) ont été négociées dans une fourchette de prix de US$ 0,033 à US$ 0,30.

Rafarma Pharmaceuticals (PK) compte actuellement 87 766 999 actions en circulation. La capitalisation boursière d'Rafarma Pharmaceuticals (PK) est de US$6,10 million. Rafarma Pharmaceuticals (PK) a un ratio cours/bénéfice (ratio PE) de 22.58.

RAFA Dernières nouvelles

Plus de nouvelles

Reverse Merger of Biocogency into Rafarma Pharmaceuticals Creates Substantial Unrealized Shareholder Value

Reverse Merger of Biocogency into Rafarma Pharmaceuticals Creates Substantial Unrealized Shareholder Value   November 17, 2020 -- InvestorsHub NewsWire -- via BioResearch Alert...

17 Novembre 2020
InvestorsHub NewsWire

Imminent Reverse Merger Brings Windfall To Rafarma Pharmaceuticals Shareholders - RAFA Shares Could Surprise Big

Imminent Reverse Merger Brings Windfall To Rafarma Pharmaceuticals Shareholders - RAFA Shares Could Surprise Big September 28, 2020 -- InvestorsHub NewsWire -- via BioResearchAlert...

28 Septembre 2020
InvestorsHub NewsWire

Rafarma Pharmaceuticals (RAFA) Announces New President as Part of Pending Acquisition of Majority Interest

MOSCOW, July 30, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc. (Pink Sheets:RAFA) announces the appointment of Mr. Bruno Horn, a Swiss citizen, as the new President and Director of the...

30 Juillet 2014
GlobeNewswire Inc.

Rafarma Pharmaceuticals (RAFA) Commences Preparation of Audited Financials

MOSCOW, May 12, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (Pink Sheets:RAFA) has commenced a formal audit to provide additional transparency in its public filings with a forward view...

12 Mai 2014
GlobeNewswire Inc.

Rafarma Pharmaceuticals (OTC:RAFA) Announces Significant Cash Flow Improvement Through Restructuring

Rafarma Pharmaceuticals (OTC:RAFA) Announces Significant Cash Flow Improvement Through Restructuring PR Newswire MOSCOW, April 10, 2014 MOSCOW, April 10, 2014 /PRNewswire/ -- In response to...

10 Avril 2014
PR Newswire (US)

Restructuring offers Assurance of Rafarma Pharmaceuticals' Improved Financial Future

Restructuring offers Assurance of Rafarma Pharmaceuticals' Improved Financial Future PR Newswire MOSCOW, April 2, 2014 MOSCOW, April 2, 2014 /PRNewswire/ -- Rafarma Pharmaceuticals Inc. (OTC...

02 Avril 2014
PR Newswire (US)

Restructuring offers Assurance of Rafarma Pharmaceuticals' Improved Financial Future

Restructuring offers Assurance of Rafarma Pharmaceuticals' Improved Financial Future PR Newswire MOSCOW, April 2, 2014 MOSCOW, April 2, 2014 /PRNewswire/ -- Rafarma Pharmaceuticals Inc. (OTC...

02 Avril 2014
PR Newswire (US)

Rafarma Pharmaceuticals (OTC:RAFA) Announces Cooperative Agreement with the St. Petersburg Academy of Pharmaceutical Chemistry

Rafarma Pharmaceuticals (OTC:RAFA) Announces Cooperative Agreement with the St. Petersburg Academy of Pharmaceutical Chemistry PR Newswire MOSCOW, Feb. 5, 2014 MOSCOW, Feb. 5, 2014 /PRNewswire/...

05 Février 2014
PR Newswire (US)

Governor's Initiative Paves Way For Pharmaceutical Joint Venture Between Rafarma Pharmaceuticals And St. Petersburg-Based Pha...

Governor's Initiative Paves Way For Pharmaceutical Joint Venture Between Rafarma Pharmaceuticals And St. Petersburg-Based Pharmsynthez PR Newswire MOSCOW, Jan. 28, 2014 MOSCOW, Jan. 28, 2014...

28 Janvier 2014
PR Newswire (US)

Rafarma Pharmaceuticals Announces a $1.2 Million Private Placement

Rafarma Pharmaceuticals Announces a $1.2 Million Private Placement PR Newswire MOSCOW, Dec. 12, 2013 MOSCOW, Dec. 12, 2013 /PRNewswire/ -- Rafarma Pharmaceuticals (OTC:RAFA), announces a $1.2...

12 Décembre 2013
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.00055-0.7333333333330.0750.0750.0641224670.06880861CS
4-0.014205-16.02278495290.0886550.09730.0605247300.07577165CS
120.0333881.27587046510.041070.120.033348070.08130438CS
260.0130521.25407166120.06140.120.033324780.07167329CS
52-0.20555-73.41071428570.280.30.033293600.11135472CS
156-0.57555-88.54615384620.650.89890.033343750.33597601CS
260-0.31595-80.92981557380.39043.790.033660760.98202292CS

RAFA - Frequently Asked Questions (FAQ)

What is the current Rafarma Pharmaceuticals (PK) share price?
The current share price of Rafarma Pharmaceuticals (PK) is US$ 0,07445
How many Rafarma Pharmaceuticals (PK) shares are in issue?
Rafarma Pharmaceuticals (PK) has 87 766 999 shares in issue
What is the market cap of Rafarma Pharmaceuticals (PK)?
The market capitalisation of Rafarma Pharmaceuticals (PK) is USD 6,1M
What is the 1 year trading range for Rafarma Pharmaceuticals (PK) share price?
Rafarma Pharmaceuticals (PK) has traded in the range of US$ 0,033 to US$ 0,30 during the past year
What is the PE ratio of Rafarma Pharmaceuticals (PK)?
The price to earnings ratio of Rafarma Pharmaceuticals (PK) is 22,58
What is the cash to sales ratio of Rafarma Pharmaceuticals (PK)?
The cash to sales ratio of Rafarma Pharmaceuticals (PK) is 0,61
What is the reporting currency for Rafarma Pharmaceuticals (PK)?
Rafarma Pharmaceuticals (PK) reports financial results in USD
What is the latest annual turnover for Rafarma Pharmaceuticals (PK)?
The latest annual turnover of Rafarma Pharmaceuticals (PK) is USD 10,14M
What is the latest annual profit for Rafarma Pharmaceuticals (PK)?
The latest annual profit of Rafarma Pharmaceuticals (PK) is USD 273k
What is the registered address of Rafarma Pharmaceuticals (PK)?
The registered address for Rafarma Pharmaceuticals (PK) is 203 S. MAIN, SUITE 3000, SHERIDAN, WYOMING, 82801
What is the Rafarma Pharmaceuticals (PK) website address?
The website address for Rafarma Pharmaceuticals (PK) is rafarma.si
Which industry sector does Rafarma Pharmaceuticals (PK) operate in?
Rafarma Pharmaceuticals (PK) operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RAASYCloopen Group Holding Limited (CE)
US$ 0,05
(4 999 900,00%)
1,59k
NEPTFNeptune Wellness Solutions Inc (CE)
US$ 0,015
(1 499 900,00%)
3,35k
HAVLFHavn Life Sciences Inc (CE)
US$ 0,001
(99 900,00%)
15,17k
STTOSITO Mobile Ltd (CE)
US$ 0,0012
(59 900,00%)
500
LTFDLittlefield Corporation (CE)
US$ 0,11
(36 566,67%)
1,8k
PRMDPrimeMD Inc (CE)
US$ 0,000001
(-99,67%)
200
NEOMNeoMedia Technologies Inc (CE)
US$ 0,000001
(-99,50%)
75,34k
AMINAmerican International Industries Inc (CE)
US$ 0,0001
(-99,50%)
1 000
SDCCQSmileDirectClub Inc (CE)
US$ 0,000001
(-99,00%)
220,31k
MAPTMAPtelligent Inc (CE)
US$ 0,000001
(-99,00%)
165k
PHILPHI Group Inc (PK)
US$ 0,0005
(66,67%)
539,33M
HMBLHUMBL Inc (PK)
US$ 0,0008
(0,00%)
282,78M
RDARRaadr Inc (PK)
US$ 0,0017
(25,93%)
220,95M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0001
(0,00%)
185,17M
TSOITherapeutic Solutions International Inc (PK)
US$ 0,0002
(-33,33%)
172,87M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
RAFA
Rafarma Pharmaceuticals (PK)
BIT
UB51ME
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés